News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Cabaletta Bio
< Previous
1
2
Next >
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 05, 2026
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces 2026 Strategic Priorities
January 12, 2026
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
November 04, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
October 27, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
October 14, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
October 09, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
August 27, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
August 07, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Pricing of Public Offering of Securities
June 11, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Proposed Public Offering of Securities
June 11, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
June 11, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
May 29, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
May 15, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 31, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
February 26, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
February 18, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
February 18, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
February 11, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
January 29, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
January 13, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Upcoming Investor Conferences in December
November 26, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
November 18, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
November 14, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
November 06, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024
September 25, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
August 28, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum
July 02, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
June 14, 2024
From
Cabaletta Bio
Via
GlobeNewswire
Tickers
CABA
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.